Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Diefenbach, DE
Christine Diefenbach, Dornburg DE
| Patent application number | Description | Published |
|---|---|---|
| 20090036565 | Dental Composites with a Low Shrinkage Tension and High Flexural Strength - Dental composite materials based on (meth)acrylate, exhibiting a proportion of TCD monomers in the total composition of 1-15% by weight and the quotient of flexural strength/shrinkage tension is at least 35. | 02-05-2009 |
| 20100076115 | Compositions For Dental Composites With Tricyclo[5.2.1.02.6]decane Derivatives - Dental composites comprising monomers, crosslinking agents, fillers, and initiators, in which the crosslinking agent comprises more than 50% by weight of the acrylate monomer TCD-DI-HEA, and the cyctotoxicity of the cured composite as determined according to the standard requirements of ISO 10993-5 and DIN EN ISO 7405 is assessed into the category “no cytotoxic potential”. | 03-25-2010 |
| 20100087565 | Dental Composites with a Low Shrinkage Tension and High Flexural Strength - Dental composite materials based on (meth)acrylate, exhibiting a proportion of TCD monomers in the total composition of 1-15% by weight and the quotient of flexural strength/shrinkage tension is at least 35. | 04-08-2010 |
Claudia Diefenbach, Stockach-Winterspuren DE
| Patent application number | Description | Published |
|---|---|---|
| 20110091889 | CENTROSOME-ASSAY - The present invention provides a centrosome assay for the identification of preferably, Eg | 04-21-2011 |
Gerhard Diefenbach, Aachen DE
| Patent application number | Description | Published |
|---|---|---|
| 20090146529 | STARTING-PROCESS CONTROLLER FOR STARTING A PIEZOMOTOR - A starting-process controller for starting a piezomotor, having a voltage-controlled oscillator, a power output stage, and a resonant converter. The oscillator generates the control signals required for the power output stage and the resonance converter converts the stepped output voltage from the power output stage into a sinusoidal voltage at the output. The resonance converter drives the piezomotor with the voltage. The motor current that flows when the piezomotor is driven is measured and compared with the phase of the drive voltage in a phase comparator. The comparison output signal is a measure of the phase difference at the time between current and voltage. A phase-locked loop filter smoothes the phase-difference signal for controling the oscillator. The controller includes a start-assisting circuit element that fixes the output voltage from the phase-locked loop filter at start-up and thus applies a constant voltage to the input of the voltage-controlled oscillator. | 06-11-2009 |
Ingo Diefenbach, Unna DE
| Patent application number | Description | Published |
|---|---|---|
| 20120013301 | Method And A Device For Charging Electric Vehicles - A method for charging electric vehicles through connecting an electric vehicle to a charging station for receiving electric energy. Different power supply offers can be selected particularly simple in that at least a state of charge of a battery and a desired duration of charge is determined in the vehicle, the energy required for fully charging the battery is determined in the vehicle, at least information concerning the required energy and the duration of charge is transmitted to the charging station by the vehicle and at least one power supply offer adapted to the information is received by the vehicle from the charging station which power supply offer has been determined from among a plurality of different power supply offers by means of the charging station using the information received. | 01-19-2012 |
Joachim Diefenbach, Rheinfelden DE
| Patent application number | Description | Published |
|---|---|---|
| 20110150739 | METHOD FOR REMOVING BORON-CONTAINING IMPURITIES FROM HALOGEN SILANES AND APPARATUS FOR PERFORMING SAID METHOD - The invention relates to a method for reducing the content of boron-containing compounds in compositions I comprising at least one silicon halide, especially of chlorosilanes of the type HnSiCI4-n with n being equal to 0, 1, 2 or 3, by introducing a small amount of moisture into the composition I in a first step and separating the hydrolyzed boron- and/or silicon-containing compounds in a second step in such a way that a pre-purified composition II having a reduced boron content is obtained, wherein, in particular, the first and second steps can be run in at least one or more cycles. Also claimed is an apparatus for performing the method and an overall system into which this apparatus is integrated. | 06-23-2011 |
Jörg Diefenbach, Stockach-Winterspuren DE
| Patent application number | Description | Published |
|---|---|---|
| 20100120730 | 6-BENZYL-2,3,4,7-TETRAHYDRO-INDOLO [2,3-C] QUINOLINE COMPOUNDS USEFUL AS PDE5 INHIBITORS - The compounds of formula (I) | 05-13-2010 |
| 20110021479 | PYRROLOPYRIMIDINECARBOXAMIDES - The compounds of Formula (I), | 01-27-2011 |
Jörg Diefenbach, Stockach-Winterspuren DE
| Patent application number | Description | Published |
|---|---|---|
| 20100120730 | 6-BENZYL-2,3,4,7-TETRAHYDRO-INDOLO [2,3-C] QUINOLINE COMPOUNDS USEFUL AS PDE5 INHIBITORS - The compounds of formula (I) | 05-13-2010 |
| 20110021479 | PYRROLOPYRIMIDINECARBOXAMIDES - The compounds of Formula (I), | 01-27-2011 |
Karl Heinz Diefenbach, Landsberg DE
| Patent application number | Description | Published |
|---|---|---|
| 20080257402 | Solar Power System with a Number of Photovoltaic Modules - The invention relates to a solar power system comprising a plurality of mounting supports ( | 10-23-2008 |
Konstanze Diefenbach, Berlin DE
| Patent application number | Description | Published |
|---|---|---|
| 20090060997 | PROCESS FOR PRODUCING A PHARMACEUTICAL PREPARATION FOR THERAPEUTIC TREATMENT OF ENDOMETRIOSIS CONTAINING A COMBINATION OF A GESTAGEN AND (6S)-5-METHYLTETRAHYDROFOLATE - A combination of an anti-androgenic gestagen at a daily dose of from an ovulation-inhibiting dose up to at most twice the ovulation-inhibiting dose and from 0.1 to 10 mg of (6S)-5-methyltetrahydrofolate are used to produce a pharmaceutical preparation for therapeutically treating endometriosis while simultaneously reducing therapy side effects including the negative effect on bone density and/or bone metabolism, reducing the risk of osteoporosis and, in the event of pregnancy, reducing the risk of congenital malformations, such as medullary tube defects, cleft lip, cleft jaw, or cleft palate, and the risk of pregnancy complications, such as detachment of the placenta and premature birth. The preparation is suitable for long-term administration, which continues daily for at least 169 days to at least two years. | 03-05-2009 |
| 20110097405 | ESTRADIOL-CONTAINING DRUG DELIVERY SYSTEM - The present invention relates to drug delivery systems in the form of thin water-soluble films (wafers), which contain estradiol, or derivatives thereof, in low amounts. The wafers of the present invention are suitable for treating, alleviating or preventing a physical condition in a female mammal caused by insufficient endogenous levels of estrogen. | 04-28-2011 |